Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...
NEW YORK, January 30, 2025--(BUSINESS WIRE)--Syntax Data, a leader in innovative financial data solutions, is proud to announce the expansion of its partnership with SmartTrust®, a leading provider of ...
NEW YORK--(BUSINESS WIRE)--Syntax Health, Inc., an enterprise SaaS-based solution for health plans and providers that accelerates alignment in value-based care (VBC), today announced the launch of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback